Follow
Assay Development
Assay Development: one of the first steps in drug development and toxicity testing is creating test systems on which to evaluate the effects of chemical compounds on cellular, molecular or biochemical processes of interest.
MAR 30, 2023 | 12:25 PM
Next-generation sequencing can detect multiple driver oncogenes simultaneously, enabling the analysis of limited amounts of biopsied tissue samples. . Druggable driver mutations cover more t...
MAR 30, 2023 | 12:25 PM
Next-generation sequencing can detect multiple driver oncogenes simultaneously, enabling the analysis of limited amounts of biopsied tissue samples. . Druggable driver mutations cover more t...
MAR 28, 2023 | 3:30 AM
Date: March 28, 2023 Time: 3:30am (PDT), 6:30am (EDT), 12:30pm (CEST) Biofluid-based neurological biomarkers have shown promise in helping to improve diagnostic accuracy, predict disease pro...
MAR 22, 2023 | 9:00 AM
We have developed 3D-shaped hydrogel microparticle platforms to capture cells, as well as isolate and label their secretions. These “lab on a particle” systems enable sorting cel...
MAR 16, 2023 | 9:00 AM
Date: March 16, 2023 Time: 9:00am (PST), 12:00pm (EST), 6:00pm (CET) Problem Screening greater than 10 pathogens or SNPs in a sample is challenging due to limitations in fluorescence colo...
MAR 08, 2023 | 1:30 PM
Spatial mapping of pain-associated G-Protein coupled receptors and bio-marker localization in mouse brain using RNAscope HiPlex v2 and RNA-Protein Co-Detection Assays....
MAR 07, 2023 | 9:00 AM
Date: March 07, 2023 Time: 9:00am (PST), 12:00pm (EST), 6:00pm (CET) The ability to synthesize and sequence vast numbers of DNA constructs is a cornerstone of modern high-throughput biologic...
FEB 22, 2023 | 1:00 PM
C.E. CREDITS
Join our webinar on diagnosing HIT: learn 4T's scoring, lab testing strategies, and practical steps for accurate clinical management....
FEB 22, 2023 | 7:30 AM
In general, once a receptor drug target has been validated for the treatment of a particular condition, either a high throughput screen is carried out to identify potential hits, or existing...
FEB 22, 2023 | 5:30 AM
Ninety percent of therapeutic agents reaching clinical trial fail to reach entry to market, with safety concerns being a major cause for failures in phase I and II clinical trials. Drug-indu...
FEB 22, 2023 | 5:30 AM
Many current technologies used in drug discovery and preclinical development programmes typically involve multi-step operations, extensive hands-on time, and lengthy liquid handling processe...
